Figure 1: (a) TCID50 against EV71 as a function of time for nine oral antiseptic products, (b) TCID50 against CA16 as a function of time for eight oral antiseptic products, (c) TCID50 against EV71 as a function of contact time for eight wound antiseptic products and (d) TCID50 against CA16 as a function of time for eight wound antiseptic products (the red horizontal dotted and dashed lines show the threshold of a 4 lg reduction in viral titer, required to demonstrate antiseptic efficacy as per EU Standard EN14476, for an initial viral titer of 9 and 8, respectively).